BIO Submits Comments Re: CY 2016 Medicare Outpatient Prospective Payment System (OPPS) Proposed Rule
<p>
Dear Acting Administrator Slavitt:</p>
<p>
The Biotechnology Industry Organization (BIO) is pleased to comment on the Centers for Medicare & Medicaid Services (CMS) proposed rule regarding payment policies under the calendar year (CY) 2016 hospital outpatient prospective payment system (OPPS), published in the Federal Register on July 8, 2015 (the “Proposed Rule”).</p>
<p>
</p>
Re: Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Short Inpatient Hospital Stays; Transition for Certain Medicare-Dependent, Small Rural Hospitals Under the Hospital Inpatient Prospective Payment System [CMS-1633-P]
Dear Acting Administrator Slavitt:
The Biotechnology Industry Organization (BIO) is pleased to comment on the Centers for Medicare & Medicaid Services (CMS) proposed rule regarding payment policies under the calendar year (CY) 2016 hospital outpatient prospective payment system (OPPS), published in the Federal Register on July 8, 2015 (the “Proposed Rule”). BIO represents biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 other nations. BIO’s members develop medical products and technologies to treat patients afflicted with serious diseases, to delay the onset of these diseases, or to prevent them in the first place.
